News
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...
Fasikl has received 510(k) clearance from the FDA for its Felix NeuroAI Wristband, designed to address tremor-related functional ...
Fresenius Medical Care (FME) has collaborated with Mexico's CCINSHAE to extend HighVolumeHDF access to individuals.
Escala Medical has pulled in €4.5m ($5.3m) to drive market expansion of its Mendit device for women with pelvic organ ...
Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...
Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...
The US FDA has granted 510(k) clearance to PathAI for its digital pathology image management system, AISight Dx.
With profound change in sight for the UK’s National Health Service (NHS), a new report indicates that a technology-driven ...
Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...
MatOrtho’s ReCerf hip resurfacing arthroplasty (HRA) has secured the CE mark, signifying its adherence to European safety standards.
InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results